Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Palix Foundation has pledged £265,250 to support a cross-disciplinary project aimed at sharing scientific knowledge about early brain development and its effect on mental health and addiction. The project will be delivered by the Department of Psychiatry and the Department of Experimental Psychology, and will unite Oxford and the foundation's shared vision of improving outcomes for children, their families and future generations.

© THE BRAIN STORY © PALIX FOUNDATION / ALBERTA FAMILY WELLNESS INITIATIVE

Lifelong health is determined by more than just our genes: experiences early in life and at other sensitive periods of development can affect our brains in ways that may impact our health as we grow older. This knowledge has important implications for both policy and practice, but despite its significance, the science behind early brain development is not widely disseminated. Front-line staff may be unfamiliar with recent advances in the field, while parents have little exposure to the science underlying the growth of their children's brains.

The Palix Foundation seeks to bridge this gap. In 2010 the foundation began disseminating the Brain Story, a narrative framework that makes scientific knowledge about early brain development accessible to policy-makers, practitioners and the public. Developed by the FrameWorks Institute and the National Scientific Council of the Developing Child, the Brain Story is shared via tools, resources and a certification course, with the aim of building resilience in families and communities around the world.

With the foundation's support, a team of researchers at Oxford will now work to embed the Brain Story locally and beyond. Under the leadership of Alan Stein, Professor of Child and Adolescent Psychiatry at the University, the team will develop a programme to explore and evaluate different ways of implementing the Brain Story, thus maximising its reach and impact.

Read more (University of Oxford Development Office)

Similar stories

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

Research programme tackling COVID-19 variants of concern receives funding boost

A gift from the Red Avenue Foundation will enable the expansion of a major research programme aimed at rapidly identifying and interrogating emerging COVID-19 variants.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.